Results from a huge epidemiological study found that infection by the Epstein-Barr virus increases the risk of developing multiple sclerosis 32-fold. This result, combined with emerging mechanistic insights into how the virus triggers brain damage, are raising the prospect of treating or preventing MS.These advances come at a time when researchers are more interested than ever in what happens in the months and years following a viral infection, and highlights the issues untangling the relationships between infectious diseases and chronic conditions.This is an audio version of our Feature: <a href="https://www.nature.com/articles/d41586-022-00808-x?utm_source=naturepod&utm_medium=podcast&utm_campaign=shownotes" rel="noopener noreferrer" target="_blank">The quest to prevent MS — and understand other post-viral diseases</a>.<hr> See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Audio long-read: The quest to prevent MS — and understand other post-viral diseases

Nature Podcast